Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Fasinumab on Peripheral Nerve Function in Osteoarthritis Pain
2017-004921-33Phase 2Unknown
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Sep 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoarthritis (OA) comparing Fasinumab with Placebo (2 arms). Status: unknown.
02
Drugs
fasinumab
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2017-004921-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004921-33.